Next Article in Journal
C8ORF88: A Novel eIF4E-Binding Protein
Previous Article in Journal
Transcriptome-Based Comparative Expression Profiling of Sweet Potato during a Compatible Response with Root-Knot Nematode Meloidogyne incognita Infection
Previous Article in Special Issue
Genes Involved in DNA Damage Cell Pathways and Health of the Oldest-Old (85+)
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Genes
Volume 14
Issue 11
10.3390/genes14112075
genes-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Variants of IFNL4 Gene in Amazonian and Northern Brazilian Populations

by
Carolina Cabral Angelim
1,
Letícia Dias Martins
1,2,
Álesson Adam Fonseca Andrade
1,
Fabiano Cordeiro Moreira
3,4,
João Farias Guerreiro
3,
Paulo Pimentel de Assumpção
4,
Sidney Emanuel Batista dos Santos
1,3 and
Greice de Lemos Cardoso Costa
1,*
1
Programa de Pós-Graduação em Agentes Infecciosos e Parasitários, Laboratório de Genética Humana e Médica, Federal University of Pará, Belém 66073-000, PA, Brazil
2
Programa de Pós-Graduação em Virologia, Instituto Evandro Chagas, Ananindeua 67030-000, PA, Brazil
3
Programa de Pós-Graduação em Genética e Biologia Molecular, Laboratório de Genética Humana e Médica, Federal University of Pará, Belém 66073-000, PA, Brazil
4
Núcleo de Pesquisa em Oncologia, Federal University of Pará, Belém 66073-000, PA, Brazil
*
Author to whom correspondence should be addressed.
Genes 2023, 14(11), 2075; https://doi.org/10.3390/genes14112075
Submission received: 15 September 2023 / Revised: 18 October 2023 / Accepted: 25 October 2023 / Published: 14 November 2023
(This article belongs to the Special Issue Genetic Variants in Human Population and Diseases)
Browse Figure
Versions Notes

Abstract

:
Since the discovery of the polymorphic nature of the IFNL4 gene, its variants have been investigated and associated with several viral diseases, with an emphasis on hepatitis C. However, the impacts of these variants on mixed-race and native populations in the northern region of Brazil are scarce. We investigated three variants of the IFNL4 gene in populations from this location, which were among the 14 most frequent variants in worldwide populations, and compared the frequencies obtained to populational data from the 1000 Genomes Project, gnomAD and ABraOM databases. Our results demonstrate that mixed-race and native populations from the northern region of Brazil present frequencies like those of European and Asian groups for the rs74597329 and rs11322783 variants, and like all populations presented for the rs4803221 variant. These data reinforce the role of world populations in shaping the genetic profile of Brazilian populations, indicate patterns of illness according to the expressed genotype, and infer an individual predisposition to certain diseases.

1. Introduction

The study of genetic variants has acquired significant importance in recent years, as it provides explanations for different clinical conditions and a profile for responses to therapeutic treatments among individuals [1]. In infectious and contagious diseases, several genes have been investigated, and especially in viral infections, the genes that encode interferons deserve to be highlighted because their translation generates proteins linked to antiviral responses [2].
Type III interferons—the family of lambda interferons (IFNL)—are considered specialists in antiviral action, blocking stages of the viral replicative cycle, increasing antigenic presentation, and triggering antiproliferative properties [3]. The notoriety of type III interferons began in 2003 with the description of IFN lambda 1 (IFNL1), lambda 2 (IFNL2) and lambda 3 (IFNL3). After 10 years of studies, a fourth type was identified, called IFN lambda 4 (IFNL4) [4]. This one stands out from the others due to its highly polymorphic character, followed by an apparent relationship with the sustained virological response (SVR) and the clearance of some viruses, justifying its importance.
The expression of IFN-λ4 occurs in several cell types, but its recognition is limited to cells that express the IFNLR1 receptor [3,5]. Studies suggest that this cytokine may have evolved specifically to protect the epithelium, as its antiviral effects may have begun before IFN-λ1, IFN-λ2 and IFN-λ3 [6]. The signaling initiated by IFN-λ4 activates the JAK-STAT pathway, leading to the expression of interferon-stimulated genes (ISGs) such as Oligoadenylate Synthetase 1 (OAS1) and Ubiquitin-specific Peptidase 18 (USP18) [1].
Studies on type III interferons emphasize how these cytokines have potential in vitro and in vivo against many viruses, such as dengue virus (DENV), cytomegalovirus (CMV), human immunodeficiency virus (HIV), and Epstein–Barr virus (EBV) [1,7]. However, the greatest potential of this gene resides in associative studies of IFNL4 variants and the spontaneous clearance of the Hepatitis C virus (HCV), with effects on therapies against this infection [8,9].
Despite the time that has passed since the discovery and description of this gene until today, there are still few studies on the impact of its variants on world populations. Proof of this are clinical data from banks such as ClinVar—National Center for Biotechnology Information; BraVE, LovD, Beacon—Brazilian Initiative on Precision Medicine—that need to be updated [10].
The study of the distribution and prevalence of genetic variants of certain genes in mixed populations is particularly important. They can indicate patterns of illness according to the expressed genotype and infer an individual’s predisposition to certain diseases [11,12,13]. It is important to focus on viral hepatitis which, according to the World Health Organization, varies in prevalence across continents due to the mode of transmission, existing viral genotypes, available prophylactic and therapeutic measures [14,15].
We add here, as a factor in this variability, the heterogeneous genotype distribution of genes such as IFNL4, especially in infections by hepatitis B (HBV) and C (HCV) viruses [16,17,18]. These diseases have a high distribution in African countries, East and Southeast Asia and European countries, and we observed that the populations of these countries have varying genotypes for the IFNL4 gene [19,20,21].
This variability is often caused by a single allele, which can condition a better or worse resolution of viral infections and therapeutic responses [22,23,24]. As an example, we have the rs12979860-C/T variant in which the allelic replacement of T by C conditioned sustained virological response (SVR) in European and Asian populations, in addition to a better response to treatments with sofosbuvir [25,26,27].
In this sense, it is understood that investigations of genetic variants such as single nucleotide polymorphisms (SNPs) and insertion or deletion (INDEL) allow the discovery and characterization of new molecular markers, with clinical applications functioning in prognosis or even in therapeutic decisions for some population groups.
Therefore, our study aimed to characterize the molecular profile of the IFNL4 gene in a mixed and native population from the Brazilian Amazon and compare these findings with data from the general Brazilian population described in the Online Archive of Brazilian Mutations (ABraOM), and world populations available in the 1000 Genomes Project and Genome Aggregation Database (gnomAD).

2. Materials and Methods

2.1. Identification of Variants

The first stage of this research was an exploratory search in the EnsEMBL (https://www.ensembl.org/index.html, accessed on 21 April 2023) database, which uses data from the 1000 Genomes Project, and GnomAD (https://gnomad.broadinstitute.org/, accessed on 22 April 2023). In these databases, we admitted the Minor Allele Frequency (MAF) on the most frequent variants (MAF > 0.05) of the IFNL4 gene and these were investigated in world populations that could serve as a reference for Brazilian populations, especially Native Americans and mixed-race people from the Northern region of Brazil.
For comparisons between the database samples and the study-elected populations, we are only considering the exon variants of this gene since we aim to investigate exome data from mixed-race and native Amazonian populations. For specifics about the Brazilian population, the source database was ABraOM (https://abraom.ib.usp.br, accessed on 22 April 2023).

2.2. Data Analysis

This section of the study was carried out in two different ways, depending on the data bank considered. For EnsEMBL, accepting that the information available stems from 1000genomes and GnomAD, carrying a worldwide perspective, the steps were laid out as: (I) Aiming for an accurate investigation and comparison of variants that were found in Amazonian populations, the data acquisition phase was designed to include Minor Allele Frequencies (MAF) 5%; (II) using the search query “IFNL4” and selecting the matching result (gene symbol report and Hugo Gene Nomenclature Committee (HGNC) ID: 44480); (III) choosing “variant table” and adjusting the MAF upwards, so the results would depict the percentages from highest to lowest; (IV) organizing a primary table on Google Docs with columns detailing populations in order of: variant (rs), all (global percentages), AFR (African Population), AMR (American Population), EAS (East Asian Population), EUR (European Population), SAS (South Asian Population); (V) from the data generated, a second organization was made on Google Spreadsheets detailing the following: chromosome, position, reference nucleotide, variant nucleotide, amino acid and protein changes, variant kind and allelic information—number, count, frequency, homozygous or heterozygous. The study condensed these and added information from our native population as well.
When considering ABraOM, we had a more local approach since this data bank only considers data generated from Brazilian populations (Data Collection from São Paulo, SP, Brazil). For this database, the steps were: (I) opening the website, selecting SA-BE-WGS-1171 (hg38) and searching for “IFNL4”; (II) selecting the highest frequency option for the variant order display; (III) exporting the data to a Google spreadsheet considering: chromosome, position, reference and variant nucleotides, category, consequence predictor (if any, using tiers of intron, exon, substitutions or unknown) rs ID and their population frequencies (same population order as the worldwide banks, with the rs information also being crossed with NCBI references), homozygous and heterozygous numbers, allele number, count and frequency were sorted highest to lowest. All data were collected and organized between April and July 2023.

2.3. Study Populations

This study uses population data described by Cohen-Paes and collaborators in 2022 [28], which includes 63 Indigenous people, representatives of the 12 Amazonian ethnicities from the northern region of Brazil. They are from Asurini do Xingu, Arara, Araweté, Asurini do Tocantins, Awa-Guajá, Kayapó/Xikrin, Zo’é, Wajãpi, Karipuna, Phurere, Munduruku and Yudjá/Juruna tribes and their ancestry was confirmed by their exomes. Table 1 summarizes demographical information about these groups and Figure 1 presents their location in Brazil.
For our comparative analysis, the Indigenous groups were called Native American Population (NAT). Furthermore, this study includes 89 mixed-race individuals from the metropolitan region of Belém (PA), which includes the cities of Belém, Ananindeua, Marituba, Benevides, Santa Barbara, Santa Izabel, Castanhal and Barcarena; referred in this work by the acronym MISC.
The study was approved by the National Research Ethics Committee and the Research Ethics Committee of the Tropical Medicine Center of the Federal University of Pará (CAE: 20654313.6.0000.5172). The participation of all individuals was conditioned on acceptance and signing of the informed consent form (ICF).
The data were compared to samples present in the databases 1000 Genomes (http://www.1000genomes.org, accessed on 19 April 2023) and GnomAD (https://gnomad.broadinstitute.org/, accessed on 19 April 2023), which are organized by presenting five continental populations including African (AFR), East Asian (EAS), South Asian (SAS), European (EUR), and American (AMR) individuals. Comparisons to the Brazilian population were obtained from the ABraOM database (https://abraom.ib.usp.br/, accessed on 19 April 2023).

2.4. DNA Extraction and Exome Library Preparation

DNA extraction occurred using the phenol-chloroform method [30]. DNA quality was assessed using the Nanodrop-8000 spectrophotometer (Thermo Fisher Scientific Inc., Wilmington, DE, USA). Library preparation used the Nextera Rapid Capture Exome (Illumina®, SanDiego, CA, USA) and SureSelect Human All Exon V6 (Agilent technologies, Santa Clara, CA, USA), following the manufacturer’s recommendations. Sequencing took place on the NextSeq 500® platform (Illumina®, San Diego, CA, USA) with use of the NextSeq 500 High-output v2 300-cycle Kit Kit (Illumina®, San Diego, CA, USA).

2.5. Bioinformatics Analysis

The resulting reads in FASTQ format were analyzed (FastQC v.0.11 http://www.bioinformatics.babraham.ac.uk/projects/fastqc/, accessed on 25 June 2023) and low-quality reads were eliminated (fastx_tools v.0.13 http://hannonlab.cshl.edu/fastx_toolkit/, accessed on 25 June 2023). The sequences were aligned with the reference genome (GRCh38) using the BWA v.0.7 tool (http://bio-bwa.sourceforge.net/, accessed on 25 June 2023).
The sequencing reads were cut to Illumina adapters and filtered using Trimmomatic v.0.36 [31] the remaining reads were aligned to the hg19 human genome reference, using BWA MEM v0.7 [32,33]. The PCR duplicates were removed via Samblaster v.0.1 [34] and the resulting mapped reads were classified and indexed making use of Samtools v1.8 [35] and Sambamba v.0.6 [36]. Lastly, the quality of the mapped bases was assessed and recalibrated with GATK v.4.0.0 BaseRecalibrator and ApplyBQSR.
Allelic variants were noted in ViVa® (Viewer of Variants, Natal, RN, Brazil). Markers in the IFNL4 gene were selected from the generated coverage (fastx_tools v.0.13-http://hannonlab.cshl.edu/fastx_toolkit (accessed on 25 June 2023)).

2.6. Statistical Analysis

The allelic frequencies were compared to verify if the mixed-race (MISC) and native (NAT) Amazonian populations present some sort of Allelic Distribution of the IFNL4 gene variants, similar to those observed in Continental and Brazilian populational groups. For that, we used the Fisher’s exact test. The results were considered statistically significant when the p value was less than 0.05 (p ≤ 0.05). The Benjamini-Hochberg False Discovery Rate (FDR) [37] test was used as a statistic correction measure applied to all the multiple tests listed. All statistical analyses were performed using the R Studio v.3.5.1 program (R Foundation for Statistical Computing, Vienna, Austria).
The LD Link tool [38] was employed to extract data referring to variant linkage disequilibrium from the ones found both in this study and in public databases, such as the 1000 Genomes Project. The results are shown through a media estimate based on the proximity between two variants (D’) in the investigated populations.

3. Results

In exploratory research, we identified 10 variants in which the altered allele was frequent in at least 10% of the populations described by the 1000 Genomes Project (MAF > 10%) and another four variants with a frequency of 5% (MAF > 5%). Among them, two variants identified in mixed-race and native populations in the northern region of Brazil had a frequency greater than 10%, and one had a frequency greater than 5%. Table 2 summarizes the characteristics of the collected variants, namely: location of the variant on the chromosome, its identification, altered alleles, variant type, and its consequence.
Exome analysis of samples from mixed-race and native Amazonians showed three of these variants being 2 SNVs (single nucleotide variant) and 1 INDEL (Insertion-Deletion). The SNV variants were rs74597329-G/T, rs4803221-C/G and are classified as moderate impact and the INDEL type variant –rs11322783-ΔT/TT–of high impact as it is a frameshift mutation.
Table 3 below presents the allelic frequencies of the IFNL4 gene variants in each of the five population groups described by GnomAD v3.1.2—Africa, Americas, East Asia, Europe, and South Asia, while Table 4 presents the frequencies observed in the 1000 Genomes Project in the same groups—the frequencies are presented in decimal number format, in both tables. They also contain the frequencies of São Paulo population obtained from the ABraOM database, serving as a basis for comparison of the frequencies observed in mixed-race and Native American populations in the Northern region of Brazil.
We observed subtle differences between data from GnomAD and the 1000 Genomes Project (Table 5 and Table 6). Pairwise comparison with data from the 1000 Genomes Project showed that the native group (NAT) differs from AFR (p-value: <0.0001), AMR (p-value: 0.0097), and São Paulo—AbraOm (p-value: 0.0097) in rs74597329 and rs11322783 variants. In the rs4803221 variant, NAT was also different from AFR (p-value: 0.0164) and AMR (p-value: 0.0031) groups. The mixed group (MISC) presented differences when compared to AFR (p-value: <0.0001) and EAS (p-value: 0.0031) for rs74597329 and rs11322783 variants. value: 0.0031) groups. The mixed group (MISC) presented differences when compared to AFR (p-value: <0.0001) and EAS (p-value: 0.0031) for rs74597329 and rs11322783 variants.
Table 6 refers to pairwise comparisons between our local data and data from GnomAD. It also shows differences between NAT, AFR, AMR and Southern Brazilian population in rs74597329 and rs11322783 variants. AMR and AFR groups also differ from NAT for rs4803221 variant (p-value: 0.016 and 0.003). Moreover, examining the mixed population, we saw that either AFR (p-value < 0.0001) and EAS (p-value = 0.0003) differs from it for rs74597329 and rs11322783 variants. The differences can also be noticed in the plot of Supplementary Materials S1. The analysis of connection imbalance between the variants observed in the present study shows a strong imbalance of these variants (r2 = 0.990; D’ = 1) in all populations already observed and, therefore, they can be analyzed as a haplotype [38].

4. Discussion

Modern-day Latin American people are the result of a complex process of mixing different genetic profiles [39]. The studies on genetics are still scarce, especially on Amazonian natives, which makes it difficult to know the specifics of their singular profile in comparison to other groups. Many authors highlight that allelic variance in genes present amongst different ethnic groups may show associations with significant consequences for human illnesses [13,40,41,42].
This can be clearly exemplified by the IFNL4 gene, whose variants may regulate IFN-λ4 expression and functionality. Interferon lambda proteins can activate the JAK-STAT pathway, leading to a positive expression of genes with antiviral properties aiming to eliminate pathogens, such as hepatitis C virus. This gene presents interesting characteristics due to a polymorphism that regulates IFN-λ4 expression; it is composed of the rs74597329 (IFNL4-G/T) and rs11322783 (IFNL4-∆/T) variants, which are in complete connection imbalance and, due to this, are analyzed together [5,10,28].
Those variants behave as a dinucleotide variation, named rs368234815 (ΔG/TT). In practical terms, this means that individuals will always have the IFNL4-ΔG (rs11322783∆/rs74597329G) and IFNL4-TT (rs11322783T/rs74597329T) haplotypes [5,28]. IFNL4-ΔG haplotype allows the formation and expression of fully functional IFN-λ4 (p179) and the IFNL4-TT haplotype alters the reading frame of the protein, creating inactive forms (p124 and p143) [10]. A paradoxical fact is discussed in the Fang [6] and Vergara [43] studies, where they show that individuals not expressing IFN-λ4 (haplotype IFNL4-TT) have higher clearance rates and better results from treatments against HCV infection.
Our study shows that the IFNL4-TT haplotype is predominant in Amazonian natives as well as in mixed and Asian populations, reaching values between 74% and 93%. The mixed group presents a profile similar to American (AMR), European (EUR), Southern Asian (SAS) and São Paulo (ABraOm) groups. It was an expected aspect since the mixed population of the study was formed by founding groups such as Europeans and Asians [44].
The differences observed when comparing the frequencies of African people to our populations of study happen because the AFR group has a differing prevalence of the ∆G haplotype when compared to all the other populations. Some authors discuss how this strong selective pressure for the IFNL4-TT haplotype may have arisen before the migration of human populations out of Africa. Due to other factors still unknown, IFNL4-TT became stronger in European and Asian groups but not in the original population. In other words, the downregulation of this protein is beneficial in many populations. [6,45]
A proposal to justify different results in American populations is given by [46]. He proposes that the genetic variations of the native populations of North, Central and South America are different due to the colonialism process and that the South American natives are even more genetically isolated from other American populations. Therefore, frequencies observed in Brazilian population groups are the result of different formation processes among our people [47].
The variant rs4803221 has controversial results. While [48,49] show G, the minor allele, as a poor predictor of viral clearance in individuals undergoing therapy with Pegylated Interferon-α (pegIFNα), and DAAs [43] discuss that this allelic variance did not impact the elimination or remaining of viral infection in Africans.
In our study, the rs4803221 variant did not show any statistically differing results on the comparison between the NAT and MISC samples and the database-checked populations. Low frequencies of minor allele (G) were observed on the NAT and EAS samples, which is expected when we evaluate the formation process of American populations, which considers American ancestry to have come from the migration of Asians by the Bering Strait [50]. However, the frequencies of the minor allele of this variant in the MISC sample are similar to those of the groups that formed it: AFR, AMR and EUR.
The SNPs rs73555604 and rs117648444 collected in the exome of the IFNL4 gene are shown in worldwide populations (GnomAd and 1000 Genomes) and in southeastern Brazil (ABraOm), but they are not present in the samples of our study. They are missense-type SNVs, and their absence in the sample of mixed-race and native Amazonians is explained by their minor frequencies of MAF in most continental populations, except for the AFR population, in which the frequencies of the lowest allele are slightly larger.
A better understanding of the genetic profile of our population is important to validate the existing hypotheses of distinct patterns in disease responses, infections, and treatments in different people. The importance of characterizing the genetics of native populations and people who have suffered intense processes of ethnic mixing is justified by essentially helping to understand illness processes that are, sometimes, unclear.
Other studies follow ours to elucidate (1) the distribution of these variants in patients with hepatitis C and (2) the direct consequences of these polymorphisms on both the HCV clearance and the efficiency of drug treatment in populations from the north of Brazil. This information will contribute knowledge and base the development of public policies aiming for health improvement in many groups across the country.

5. Conclusions

The results indicate that the variants rs74597329, rs11322783 and rs4803221 of the IFNL4 gene evaluated in mixed-race and native populations from the northern region of Brazil have frequencies resembling those in world populations, especially Asian and European ones. In practical terms, these results suggest that world populations played a significant role in the formation of the Brazilian population. Therefore, this study aid further future public policies associated with the treatment of viral infections in these populational groups.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/genes14112075/s1.

Author Contributions

Conceptualization, S.E.B.d.S. and G.d.L.C.C.; Data curation, J.F.G.; Formal analysis, P.P.d.A., S.E.B.d.S., F.C.M. and G.d.L.C.C.; Investigation, C.C.A., L.D.M. and Á.A.F.A.; Methodology, F.C.M., G.d.L.C.C., J.F.G., P.P.d.A. and S.E.B.d.S.; Supervision, G.d.L.C.C.; Validation, J.F.G. and P.P.d.A.; Visualization, L.D.M., Á.A.F.A. and J.F.G.; Writing—original draft, C.C.A.; Writing—review and editing, C.C.A., L.D.M. and G.d.L.C.C. All authors have read and agreed to the published version of the manuscript.

Funding

This work is part of the Rede de Pesquisa em Genômica Populacional Humana (Biocomputacional Protocol No. 3381/2013/CAPES), FAPESPA (Amazon Foundation for the Support of Studies and Research) and Pro-rector of Research and Post-graduation (Propesp) of the Federal University of Para supported this work. The authors C.C.A, L.D.M and Á.A.F.A were also contemplated with governmental scholarships according to the ID numbers 130241/2023-7 from CNPq (Council for Scientific and Technological Development), 88887.842950/2023-00 and 88887.940110/2023-00 from CAPES (Coordination for the Improvement of Higher Education Personnel), respectively.

Institutional Review Board Statement

The study was approved by the National Research Ethics Committee and the Research Ethics Committee of the Tropical Medicine Center of the Federal University of Pará (CAE: 20654313.6.0000.5172) on 18 December 2018.

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Data Availability Statement

Data are contained within the article and Supplementary Materials.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Syedbasha, M.; Egli, A. Interferon Lambda: Modulating Immunity in Infectious Diseases. Front. Immunol. 2017, 8, 119. [Google Scholar]
  2. Hemann, E.A.; Gale, M.; Savan, R. Interferon Lambda Genetics and Biology in Regulation of Viral Control. Front. Immunol. 2017, 8, 1707. [Google Scholar] [CrossRef]
  3. Ye, L.; Schnepf, D.; Staeheli, P. Interferon-λ orchestrates innate and adaptive mucosal immune responses. Nat. Rev. Immunol. 2019, 19, 614–625. [Google Scholar] [CrossRef]
  4. Bruening, J.; Weigel, B.; Gerold, G. The Role of Type III Interferons in Hepatitis C Virus Infection and Therapy. J. Immunol. Res. 2017, 2017, 7232361. [Google Scholar] [CrossRef]
  5. O’Brien, T.R.; Prokunina-Olsson, L.; Donnelly, R.P. IFN-λ4: The Paradoxical New Member of the Interferon Lambda Family. J. Interferon Cytokine Res. 2014, 34, 829–838. [Google Scholar] [CrossRef]
  6. Fang, M.Z.; Jackson, S.S.; O’Brien, T.R. IFNL4: Notable variants and associated phenotypes. Gene 2020, 730, 144289. [Google Scholar] [CrossRef]
  7. Rugwizangoga, B.; Andersson, M.E.; Kabayiza, J.C.; Nilsson, M.S.; Ármannsdóttir, B.; Aurelius, J.; Nilsson, S.; Hellstrand, K.; Lindh, M.; Martner, A. IFNL4 Genotypes Predict Clearance of RNA Viruses in Rwandan Children with Upper Respiratory Tract Infections. Front. Cell. Infect. Microbiol. 2019, 9, 340. [Google Scholar] [CrossRef]
  8. Bhushan, A.; Chinnaswamy, S. Identifying causal variants at the interferon lambda locus in case-control studies: Utilizing non-synonymous variant rs117648444 to probe the role of IFN-λ4. Gene 2018, 664, 168–180. [Google Scholar] [CrossRef]
  9. Prokunina-Olsson, L. Genetics of the Human Interferon Lambda Region. J. Interferon Cytokine Res. 2019, 39, 599–608. [Google Scholar] [CrossRef]
  10. National Center for Biotechnology Information. ClinVar; [VCV000225949.4]. Available online: https://www.ncbi.nlm.nih.gov/clinvar/variation/VCV000225949.4 (accessed on 3 May 2023).
  11. Pinto, P.; Salgado, C.; Santos, N.P.C.; Santos, S.; Ribeiro-dos-Santos, Â. Influence of Genetic Ancestry on INDEL Markers of NFKβ1, CASP8, PAR1, IL4 and CYP19A1 Genes in Leprosy Patients. PLOS Neglected Trop. Dis. 2015, 9, e0004050. [Google Scholar] [CrossRef]
  12. Leal, D.F.d.V.B.; da Silva, M.N.S.; Fernandes, D.C.R.d.O.; Rodrigues, J.C.G.; Barros, M.C.d.C.; Pinto, P.D.d.o.C.; Pastana, L.F.; Silva, C.A.; Fernandes, M.R.; Assumpção, P.P.; et al. Amerindian genetic ancestry as a risk factor for tuberculosis in an amazonian population. PLoS ONE 2020, 15, e0236033. [Google Scholar]
  13. Carvalho, D.C.; Wanderley, A.V.; dos Santos, A.M.R.; Moreira, F.C.; de Sá, R.B.A.; Fernandes, M.R.; Modesto, A.A.; de Souza, T.P.; Cohen-Paes, A.; Leitão, L.P.; et al. Characterization of pharmacogenetic markers related to Acute Lymphoblastic Leukemia toxicity in Amazonian native Americans population. Sci. Rep. 2020, 10, 10292. [Google Scholar] [CrossRef] [PubMed]
  14. World Health Organization (WHO). Hepatitis. Health Topics. Available online: https://www.who.int/health-topics/hepatitis#tab=tab_1 (accessed on 4 May 2023).
  15. Cuautle-Rodríguez, P.; Llerena, A.; Molina-Guarneros, J. Present status, and perspective of pharmacogenetics in Mexico. Drug Metab. Drug Interact. 2014, 29, 37–45. [Google Scholar]
  16. Nastri, A.C.S.S.; Malta, F.M.; Diniz, M.A.; Yoshino, A.; Abe-Sandes, K.; dos Santos, S.E.B.; de Castro Lyra, A.; Carrilho, F.J.; Pinho, J.R. Association of IFNL3 and IFNL4 polymorphisms with hepatitis C virus infection in a population from southeastern Brazil. Arch. Virol. 2016, 161, 1477–1484. [Google Scholar] [CrossRef]
  17. Ma, N.; Zhang, X.; Yang, L.; Zhou, J.; Liu, W.; Gao, X.; Yu, F.; Zheng, W.; Ding, S.; Gao, P.; et al. Role of Functional IFNL4, IFNLR1, IFNA, IFNAR2Polymorphisms in Hepatitis B virus-related liver disease in Han Chinese population. J. Viral Hepat. 2017, 25, 306–313. [Google Scholar] [CrossRef]
  18. Gonzalez-Aldaco, K.; Rebello Pinho, J.R.; Roman, S.; Gleyzer, K.; Fierro, N.A.; Oyakawa, L.; Ramos-Lopez, O.; Ferraz Santana, R.A.; Sitnik, R.; Panduro, A.; et al. Association with Spontaneous Hepatitis C Viral Clearance and Genetic Differentiation of IL28B/IFNL4 Haplotypes in Populations from Mexico. PLoS ONE 2016, 11, e0146258. [Google Scholar]
  19. Jefferies, M.; Rauff, B.; Rashid, H.; Lam, T.; Rafiq, S. Update on global epidemiology of viral hepatitis and preventive strategies. World J. Clin. Cases 2018, 6, 589–599. Available online: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6232563/ (accessed on 4 April 2023).
  20. Razavi, H. Global Epidemiology of Viral Hepatitis. Gastroenterol. Clin. N. Am. 2020, 49, 179–189. [Google Scholar]
  21. Sant’Anna, T.B.; Araujo, N.M. Hepatitis B Virus Genotype D: An Overview of Molecular Epidemiology, Evolutionary History, and Clinical Characteristics. Microorganisms 2023, 11, 1101. [Google Scholar]
  22. Pedergnana, V.; Irving, W.L.; Barnes, E.; McLauchlan, J.; Spencer, C.C.A. Impact of IFNL4 Genetic Variants on Sustained Virologic Response and Viremia in Hepatitis C Virus Genotype 3 Patients. J. Interferon Cytokine Res. 2019, 39, 642–649. [Google Scholar] [CrossRef]
  23. Galmozzi, E.; Facchetti, F.; Grossi, G.; Loglio, A.; Viganò, M.; Lunghi, G.; Colombo, M.; Lampertico, P. IFNL4 rs368234815 and rs117648444 variants predict off-treatment HBsAg seroclearance in IFN-treated HBeAg-negative chronic hepatitis B patients. Liver Int. 2017, 38, 417–423. [Google Scholar] [CrossRef] [PubMed]
  24. De Re, V.; Tornesello, M.L.; De Zorzi, M.; Caggiari, L.; Pezzuto, F.; Leone, P.; Racanelli, V.; Lauletta, G.; Zanussi, S.; Repetto, O.; et al. PDCD1 and IFNL4 genetic variants and risk of developing hepatitis C virus-related diseases. Liver Int. 2020, 41, 133–149. [Google Scholar]
  25. Luo, Y.; Jin, C.; Ling, Z.; Mou, X.; Zhang, Q.; Xiang, C. Association study of IL28B: rs12979860 and rs8099917 polymorphisms with SVR in patients infected with chronic HCV genotype 1 to PEG-INF/RBV therapy using systematic meta-analysis. Gene 2013, 513, 292–296. [Google Scholar] [CrossRef]
  26. Ragheb, M.M.; Nemr, N.A.; Kishk, R.M.; Mandour, M.F.; Abdou, M.M.; Matsuura, K.; Watanabe, T.; Tanaka, Y. Strong prediction of virological response to combination therapy by IL28B gene variants rs12979860 and rs8099917 in chronic hepatitis C genotype 4. Liver Int. 2014, 34, 890–895. [Google Scholar] [CrossRef]
  27. Prokunina-Olsson, L.; Muchmore, B.; Tang, W.; Pfeiffer, R.M.; Park, H.; Dickensheets, H.; Hergott, D.; Porter-Gill, P.; Mumy, A.; Kohaar, I.; et al. A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus. Nat. Genet. 2013, 45, 164–171. [Google Scholar] [CrossRef]
  28. Cohen-Paes, A.d.N.; de Carvalho, D.C.; Pastana, L.F.; Dobbin, E.A.F.; Moreira, F.C.; de Souza, T.P.; Fernandes, M.R.; Leal, D.F.; de Sá, R.B.; de Alcântara, A.L.; et al. Characterization of PCLO Gene in Amazonian Native American Populations. Genes 2022, 13, 499. [Google Scholar] [CrossRef]
  29. Garcia, U. Crônicas de caça e Criação; Hedra: São Paulo, Brazil, 2022. [Google Scholar]
  30. Sambrook, J.; Green, M.R. Molecular Cloning: A Laboratory Manual, 4th ed.; Cold Spring Harbor Laboratory Press: Cold Spring Harbor, NY, USA, 2012. [Google Scholar]
  31. Bolger, A.M.; Lohse, M.; Usadel, B. Trimmomatic: A flexible trimmer for Illumina sequence data. Bioinformatics 2014, 30, 2114–2120. [Google Scholar] [CrossRef]
  32. Li, H.; Durbin, R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 2009, 25, 1754–1760. [Google Scholar] [CrossRef]
  33. Li, H. Aligning Sequence Reads, Clone Sequences and Assembly Contigs with BWA-MEM. arXiv 2013, arXiv:1303.3997. [Google Scholar]
  34. Faust, G.G.; Hall, I.M. SAMBLASTER: Fast duplicate marking and structural variant read extraction. Bioinformatics 2014, 30, 2503–2505. [Google Scholar] [CrossRef]
  35. Li, H.; Handsaker, B.; Wysoker, A.; Fennell, T.; Ruan, J.; Homer, N.; Marth, G.; Abecasis, G.; Durbin, R.; 1000 Genome Project Data Processing Subgroup. The Sequence Alignment/Map format and SAMtools. Bioinformatics 2009, 25, 2078. [Google Scholar] [CrossRef] [PubMed]
  36. Tarasov, A.; Vilella, A.J.; Cuppen, E.; Nijman, I.J.; Prins, P. Sambamba: Fast processing of NGS alignment formats. Bioinformatics 2015, 31, 2032–2034. [Google Scholar] [CrossRef]
  37. Benjamini, Y.; Hochberg, Y. Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. J. R. Stat. Soc. Ser. B 1995, 57, 289–300. [Google Scholar] [CrossRef]
  38. Machiela, M.J.; Chanock, S.J. LDlink: A web-based application for exploring population-specific haplotype structure and linking correlated alleles of possible functional variants: Fig. 1. Bioinformatics 2015, 31, 3555–3557. [Google Scholar] [CrossRef]
  39. Salzano, F.M. Genetic diversity of South American human populations at the DNA and protein levels. J. Exp. Zool. 1998, 282, 157–163. [Google Scholar] [CrossRef]
  40. Rodrigues, J.C.G.; Fernandes, M.R.; Guerreiro, J.F.; da Silva, A.L.D.C.; Ribeiro-Dos-Santos, Â.; Santos, S.; Santos, N.P. Polymorphisms of ADME-related genes and their implications for drug safety and efficacy in Amazonian Amerindians. Sci. Rep. 2019, 9, 7201. [Google Scholar] [CrossRef]
  41. Rodrigues, J.C.G.; de Souza, T.P.; Pastana, L.F.; dos Santos, A.M.R.; Fernandes, M.R.; Pinto, P.; Wanderley, A.V.; de Souza, S.J.; Kroll, J.E.; Pereira, A.L.; et al. Identification of NUDT15 gene variants in Amazonian Amerindians and admixed individuals from northern Brazil. PLoS ONE 2020, 15, e0231651. [Google Scholar] [CrossRef]
  42. Dobbin, E.A.F.; Medeiros, J.A.G.; Costa, M.S.C.R.; Rodrigues, J.C.G.; Guerreiro, J.F.; Kroll, J.E.; Souza, S.J.; de Assumpção, P.P.; Ribeiro-dos-Santos, Â.; Santos, S.E.; et al. Identification of Variants (rs11571707, rs144848, and rs11571769) in the BRCA2 Gene Associated with Hereditary Breast Cancer in Indigenous Populations of the Brazilian Amazon. Genes 2021, 12, 142. [Google Scholar] [CrossRef] [PubMed]
  43. Vergara, C.; Thio, C.L.; Johnson, E.; Kral, A.H.; O’brien, T.R.; Goedert, J.J.; Mangia, A.; Piazzolla, V.; Mehta, S.H.; Kirk, G.D.; et al. Multi-Ancestry Genome-Wide Association Study of Spontaneous Clearance of Hepatitis C Virus. Gastroenterology 2019, 156, 1496–1507. [Google Scholar] [CrossRef] [PubMed]
  44. Santos, N.P.; Ribeiro-Rodrigues, E.M.; Ribeiro-Dos-Santos, K.; Pereira, R.; Gusmão, L.; Amorim, A.; Guerreiro, J.F.; Zago, M.A.; Matte, C.; Hutz, M.H.; et al. Assessing individual interethnic admixture and population substructure using a 48-insertion-deletion (INSEL) ancestry-informative marker (AIM) panel. Hum. Mutat. 2010, 31, 184–190. [Google Scholar] [CrossRef]
  45. Key, F.M.; Peter, B.; Dennis, M.Y.; Huerta-Sánchez, E.; Tang, W.; Prokunina-Olsson, L.; Nielsen, R.; Andrés, A.M. Selection on a Variant Associated with Improved Viral Clearance Drives Local, Adaptive Pseudogenization of Interferon Lambda 4 (IFNL4). PLoS Genet. 2014, 10, e1004681. [Google Scholar] [CrossRef] [PubMed]
  46. Wang, S.; Lewis, C.M.; Jakobsson, M.; Ramachandran, S.; Ray, N.; Bedoya, G.; Rojas, W.; Parra, M.V.; A Molina, J.; Gallo, C.; et al. Genetic Variation and Population Structure in Native Americans. PLoS Genet. 2007, 3, e185. [Google Scholar] [PubMed]
  47. Amador, M.A.; Cavalcante, G.C.; Santos, N.P.; Gusmão, L.; Guerreiro, J.F.; Ribeiro-dos-Santos, Â.; Santos, S. Distribution of allelic and genotypic frequencies of IL1A, IL4, NFKB1 and PAR1 variants in Native American, African, European and Brazilian populations. BMC Res. Notes 2016, 9, 101. [Google Scholar] [CrossRef] [PubMed]
  48. Smith, K.R.; Suppiah, V.; O’Connor, K.; Berg, T.; Weltman, M.; Abate, M.L.; Spengler, U.; Bassendine, M.; Matthews, G.; Irving, W.L.; et al. Identification of improved IL28B SNPs and haplotypes for prediction of drug response in treatment of hepatitis C using massively parallel sequencing in a cross-sectional European cohort. Genome Med. 2011, 3, 57. [Google Scholar] [CrossRef] [PubMed]
  49. Booth, D.R.; Ahlenstiel, G.; George, J. Pharmacogenomics of hepatitis C infections: Personalizing therapy. Genome Med. 2012, 4, 99. [Google Scholar] [CrossRef]
  50. Skoglund, P.; Reich, D. A genomic view of the peopling of the Americas. Curr. Opin. Genet. Dev. 2016, 41, 27–35. [Google Scholar] [CrossRef]
Genes 14 02075 g001
Figure 1. Location of Amazonian tribes present in this study. Image made on QGIS 3.28.0 software.
Figure 1. Location of Amazonian tribes present in this study. Image made on QGIS 3.28.0 software.
Genes 14 02075 g001
Table 1. Populational groups demographics including the tribes, their location, number of habitants and data source.
Table 1. Populational groups demographics including the tribes, their location, number of habitants and data source.
TribeLocationStatePopulation (N)Source
Asurini do XinguAltamira, Senador José PorfírioPará182SIASI
Arara/Arara do IririAltamira, Brasil novo, Medicilância, UruaráPará298SIASI
ArawetéAltamira, São Félix do Xingu e Senador José PorfírioPará467SIASI
Asurini do TocantinsBaião e TucuruíPará565SIASI
Awa-GuajáArariboiaMaranhão520[29]
Kayapó/XikrinIL Bacajá (Altamira, Anapu, São Félix do Xingu, Senador José PorfírioPará746FUNAI
IL Xikrin do Cateté (Água Azu do Norte,
Marabá, Parauapebas)		Pará1183SIASI
Zo’éÓbidosPará330IEPE
WajãpiLaranjal do Jari, Mazagão, Pedra Branca do AmapariPará1454DSEI/AP
KaripunaTI Galibe (Oiapoque)Amapá151SIASI
TI Juminá (Oiapoque)Amapá291IEPE
Uaçá I e II (Oiapoque)Amapá4462FUNAI
PhurereMarabáPará
MundurukuItaituba e JacareacangaPará6518SIASI
Yudjá/JurunaVitória do XinguPará95SIASI
Acronyms: IL—Indigenous land, SIASI—Indigenous Health Care Information System, FUNAI—National Foundation of Indigenous Peoples, DSEI—Special Indigenous Health Districts, IEPE—Special Indigenous Health Districts.
Table 2. Characterization of variants of the IFNL4 gene investigated in distinct groups: African, American, East Asian, European, South Asian, Brazilian from São Paulo, mixed-race, and Native American populations from the Northern region of Brazil.
Table 2. Characterization of variants of the IFNL4 gene investigated in distinct groups: African, American, East Asian, European, South Asian, Brazilian from São Paulo, mixed-race, and Native American populations from the Northern region of Brazil.
Genomic PositionSNP IdentifierNucleotideVariantConsequence
19:39246873rs12979731T > CSNV3′UTR variant
19:39246936rs370209610T > CSNV3′UTR variant
19:39246970rs11882871G > ASNV3′UTR variant
19:39247226rs12971396C > GSNV3′UTR variant
19:39247247rs137902769A > TSNV3′UTR variant
19:39247389rs73555604C > TSNVmissense variant
19:39247677rs111531283C > ASNVintron variant
19:39247938rs117648444G > ASNVmissense variant
19:39248147rs12979860T > CSNVintron variant
19:39248489rs4803221C > GSNVmissense variant
19:39248514rs11322783T > TTINDELframeshift variant
19:39248515rs74597329G > TSNVmissense variant
19:39248713rs4803222G > CSNV5′UTR variant
19:39737578rs570739705C > GSNV3′UTR variant
Table 3. Frequencies of IFNL4 gene variants investigated in African (AFR), American (AMR), East Asian (EAS), European (EUR), South Asian (SAS) from GnomAD, Brazilian population from Online Archive of Brazilian Mutations (ABraOm), mixed-race (MISC) and Native American populations from the Northern region of Brazil (NAT).
Table 3. Frequencies of IFNL4 gene variants investigated in African (AFR), American (AMR), East Asian (EAS), European (EUR), South Asian (SAS) from GnomAD, Brazilian population from Online Archive of Brazilian Mutations (ABraOm), mixed-race (MISC) and Native American populations from the Northern region of Brazil (NAT).
SNP IDAllelesAFRAMREAS EURSASABraOmMISCNAT
rs74597329 *T0.3640.6210.9320.6830.7660.6240.7440.838
G0.6360.3790.0680.3170.2340.3760.2560.162
rs4803221 *C0.7740.7210.9360.7970.8450.780.8320.937
G0.2260.2790.0640.2030.1550.220.1690.064
rs73555604C0.8010.9770.9990.980.9840.952
T0.1990.0230.0010.020.0160.048
rs117648444G0.9320.9370.9950.9060.950.921
A0.0680.0630.0050.0940.050.079
rs11322783 *TT0.3640.6210.9320.6830.7660.6240.7440.838
T-0.6360.3790.0680.3170.2340.3760.2560.162
Shaded lines represent the frequencies of major allele and non-shaded represent minor allele. * Represents the SNVs evaluated in native and mixed populations.
Table 4. Frequencies of variants of the IFNL4 gene investigated in African (AFR), American (AMR), East Asian (EAS), European (EUR), South Asian (SAS) populations from the 1000 Genomes Project, Brazilian population from Online Archive of Brazilian Mutations (ABraOm), mixed-race (MISC) and Native Americans from the Northern region of Brazil (NAT).
Table 4. Frequencies of variants of the IFNL4 gene investigated in African (AFR), American (AMR), East Asian (EAS), European (EUR), South Asian (SAS) populations from the 1000 Genomes Project, Brazilian population from Online Archive of Brazilian Mutations (ABraOm), mixed-race (MISC) and Native Americans from the Northern region of Brazil (NAT).
SNP IDAllelesAFRAMREASEURSASABraOmMISCNAT
rs74597329 *T0.2930.5970.920.6880.7580.6240.7440.838
G0.7070.4030.080.3120. 2420.3760.2560.162
rs4803221 *C0.8370.70.9250.8280.8340.780.8320.937
G0.1630.30.0750.1720.1660.220.1690.064
rs73555604C0.7370.97610.9830.9790.952
T0.2630.024 0.0170.0210.048
rs117648444G0.9250.9350.9950.8820.9560.921
A0.0750.0650.0050.1180.0440.079
rs11322783 *T-0.7070.4030.0810.3110.2390.3760.2560.162
TT0.2930.5970.9190.6890.7610.6240.7440.838
Shaded lines represent the frequencies of major allele and non-shaded represent minor allele. * Represents the SNVs evaluated in native and mixed populations.
Table 5. Pairwise comparison (p-value) of allelic frequencies in Native, Mixed-population and with each one of the five continental populations from the 1000 Genomes Project database for IFNL4 gene variants investigated.
Table 5. Pairwise comparison (p-value) of allelic frequencies in Native, Mixed-population and with each one of the five continental populations from the 1000 Genomes Project database for IFNL4 gene variants investigated.
rs74597329rs4803221rs11322783
AFR vs. MISC<0.00010.4549<0.0001
AMR vs. MISC0.13950.13950.1395
EAS vs. MISC0.00310.05850.0031
EUR vs. MISC0.49760.77340.4976
SAS vs. MISC0.773410.7734
ABraOm vs. MISC0.13950.52940.1395
MISC vs. NAT0.22810.13950.2281
AFR vs. NAT<0.00010.0164<0.0001
AMR vs. NAT0.00970.00310.0097
EAS vs. NAT0.165910.1659
EUR vs. NAT0.06380.05850.0638
SAS vs. NAT0.41310.13950.4131
ABraOm vs. NAT0.00970.0250.0097
Shaded cells represent significant differences between two populations (p-value < 0.05).
Table 6. Pairwise comparison (p-value) of allelic frequencies in Native, Mixed-population and with each one of the five continental populations from GnomAD database for IFNL4 gene variants investigated.
Table 6. Pairwise comparison (p-value) of allelic frequencies in Native, Mixed-population and with each one of the five continental populations from GnomAD database for IFNL4 gene variants investigated.
rs74597329rs4803221rs11322783
AFR vs. MISC<0.00010.4579<0.0001
AMR vs. MISC0.14170.14170.1417
EAS vs. MISC0.00030.0570.0003
EUR vs. MISC0.49990.77450.4999
SAS vs. MISC0.774510.7745
ABraOm vs. MISC0.14170.53130.1417
MISC vs. NAT0.23030.14170.2303
AFR vs. NAT<0.00010.016<0.0001
AMR vs. NAT0.00950.0030.0095
EAS vs. NAT0.167910.1679
EUR vs. NAT0.06220.0570.0622
SAS vs. NAT0.41620.14170.4162
ABraOm vs. NAT0.00950.02440.0095
Shaded cells represent significant differences between two populations (p-value < 0.05).
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Angelim, C.C.; Martins, L.D.; Andrade, Á.A.F.; Moreira, F.C.; Guerreiro, J.F.; de Assumpção, P.P.; Santos, S.E.B.d.; Costa, G.d.L.C. Variants of IFNL4 Gene in Amazonian and Northern Brazilian Populations. Genes 2023, 14, 2075. https://doi.org/10.3390/genes14112075

AMA Style

Angelim CC, Martins LD, Andrade ÁAF, Moreira FC, Guerreiro JF, de Assumpção PP, Santos SEBd, Costa GdLC. Variants of IFNL4 Gene in Amazonian and Northern Brazilian Populations. Genes. 2023; 14(11):2075. https://doi.org/10.3390/genes14112075

Chicago/Turabian Style

Angelim, Carolina Cabral, Letícia Dias Martins, Álesson Adam Fonseca Andrade, Fabiano Cordeiro Moreira, João Farias Guerreiro, Paulo Pimentel de Assumpção, Sidney Emanuel Batista dos Santos, and Greice de Lemos Cardoso Costa. 2023. "Variants of IFNL4 Gene in Amazonian and Northern Brazilian Populations" Genes 14, no. 11: 2075. https://doi.org/10.3390/genes14112075

APA Style

Angelim, C. C., Martins, L. D., Andrade, Á. A. F., Moreira, F. C., Guerreiro, J. F., de Assumpção, P. P., Santos, S. E. B. d., & Costa, G. d. L. C. (2023). Variants of IFNL4 Gene in Amazonian and Northern Brazilian Populations. Genes, 14(11), 2075. https://doi.org/10.3390/genes14112075

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop